CpG oligodeoxynucleotide-induced immunity prevents growth of germinal center-derived B lymphoma cells
- 20 December 2006
- journal article
- Published by Elsevier BV in International Immunopharmacology
- Vol. 6 (13-14), 2057-2068
- https://doi.org/10.1016/j.intimp.2006.08.008
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- B-Cell Lymphomas Differ in their Responsiveness to CpG OligodeoxynucleotidesClinical Cancer Research, 2005
- Polymyxin B enhances ISS-mediated immune responses across multiple speciesCellular Immunology, 2004
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12European Journal of Immunology, 2001
- Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cellsEuropean Journal of Immunology, 2001
- Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitisEuropean Journal of Immunology, 2000
- Superantigens related to B cell hyperplasiaSpringer Seminars in Immunopathology, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouseClinical Immunology and Immunopathology, 1992
- T-helper-cell-specific monoclonal antibody inhibits growth of B-cell lymphomas in syngeneic SJL/J miceCellular Immunology, 1989